FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry, in particular to creation of pharmaceutical compositions for treatment of allergic and inflammatory skin diseases, which contain glucocorticosteroid, synthetic polymer highly molecular compound and ointment base, with the following component ration, wt %: glucocorticosteroid 0.002-0.08. Synthetic polymer highly molecular compound 0.5-15 ointment base to 100.
EFFECT: claimed pharmaceutical composition is efficient in treatment of inflammatory and allergic skin diseases.
4 cl, 7 dwg, 2 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR ALLERGIC AND INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2440108C2 |
AGENT FOR TREATING LOCAL ALLERGIC EXUDATIVE-INFLAMMATORY AND INFILTRATIVE-INFLAMMATORY SKIN PROCESSES | 2009 |
|
RU2417086C1 |
MEDICATION FOR TREATING DERMATOSIS (VERSIONS) | 2013 |
|
RU2548764C2 |
COMBINED PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION | 2018 |
|
RU2736940C2 |
PHARMACEUTICAL COMPOSITION, CONTAINING DERIVATIVES OF GLUTARIMIDES, AND THEIR APPLICATION FOR TREATMENT OF EOSINOPHILIC DISEASES | 2013 |
|
RU2552929C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING DERMATOSES THAT CAN BE TREATED BY GLUCOCORTICOSTEROID THERAPY, AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2396081C1 |
TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING COMBINATION OF FUSIDIC ACID AND CORTICOSTEROID | 2008 |
|
RU2470645C2 |
TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
BROAD-SPECTRUM OINTMENT FOR ALLERGIC DERMOPATHIES | 2008 |
|
RU2353348C1 |
Authors
Dates
2011-06-10—Published
2009-05-25—Filed